Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
673 5 |
Ultima descărcare din IBN: 2023-08-28 15:10 |
Căutarea după subiecte similare conform CZU |
616.36-002-036.1-07-085 (1) |
Patologia sistemului digestiv. Tulburări ale tubului alimentar (1732) |
SM ISO690:2012 LUPAŞCO, Iulianna. Hepatitele cronice ( factori de risc, aspecte clinico -metabolice de diagnostic) şi eficacitatea tratamentului antiviral. In: Sănătate Publică, Economie şi Management în Medicină , 2015, nr. 1(58), pp. 46-58. ISSN 1729-8687. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Sănătate Publică, Economie şi Management în Medicină | ||||||
Numărul 1(58) / 2015 / ISSN 1729-8687 /ISSNe 2587-3873 | ||||||
|
||||||
CZU: 616.36-002-036.1-07-085 | ||||||
Pag. 46-58 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
The aim of the study was to investigate the prevalence of chronic hepatitis B and other chronic diffuse liver diseases (CDDL) in the adult population of the country by conducting prophylactic inspections, the identification of risk factors, description of the clinical aspects of the metabolic and hormonal changes in patients with CDDL, the development of optimal parameters of diagnosis and differential diagnosis of CDLD. Of the 1451 surveyed, CDLD was diagnosed in 41,02%, among which 26,70% presented CH, hepatopathy – 51,60%, fatty liver – 18,32%, liver cirrhosis – 3,36%. There were found risk factors of CDLD. Diagnosed major changes of liver syndromes markers and hormonal profile allowed developing of optimal methods of diagnosis of various forms CDLD. There were established specific features of different forms of chronic hepatitis B and C. Was demonstrated the efficacy of antiviral therapy (interferon α2β + ribavirin) in CHC (70,83%). Examination of liver syndromes markers and the hormones involved in their activation and regulation is useful for understanding the pathogenetic mechanisms of chronic hepatitis and other forms of liver disease, for timely correction of hormonal and metabolic imbalance. |
||||||
Cuvinte-cheie chronic hepatitis, antiviral therapy, hormonal profile |
||||||
|